Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anthony Barron
5 Frames... Of the peripheries of Boston on JCH StreetPan 400 (35mm Format / EI 200 / Pentax K1000 + SMC Pentax-A f/2 50mm) - by Anthony L. Barron
On an early spring day I walked over to my local camera store; I’m lucky enough to live in city that still has one. I was looking for a lens cap cover for my camera. It was recently cleaned and repaired after years of abuse and the light meter was once again functional. While I was there, I asked to see if there was any odd or different film for sale. The owner pulled out a tray filled with rolls of 35 mm film, each one left in a bag or thrown in from the various cameras he’s bought.
Anthony L. Barron
On an early spring day I walked over to my local camera store; I’m lucky enough to live in city that still has one. I was looking for a lens cap cover for my camera. It was recently cleaned and repaired after years of abuse and the light meter was once again functional. While I […]
Digital Health Technologies: The Evolving Landscape Of Reimbursement & 4 Strategies To Consider
By Eva Marchese, Lev Gerlovin, Lorenzo D’Angelo, and Anthony Barron, Life Sciences Practice, CRA The use of digital health technologies (DHTs), ranging from devices and apps to cloud-based services and artificial intelligence platforms, has accelerated rapidly in recent years, especially in response to the COVID-19 pandemic.
Overcoming Funding Challenges For Innovative Medtech In Germany: Learnings From The NUB Process
By Eva Marchese, Lorenzo D’Angelo, Anthony Barron, and Oriol Viader-Llargués, CRA Germany is the leading medtech market in Europe, with a 22% market share. While funding for high-cost innovative medtech in Germany has evolved in recent years, there are still many challenges in securing reimbursement even as demand for these technologies surges.
Can “Risk-Sharing” Agreements Enable Fast Access to COVID-19 Vaccines?
As the global COVID-19 pandemic has progressed, so too have efforts to develop, manufacture, and secure the supply of potentially effective vaccines. At the time of writing, more than 45 vaccine candidates have entered clinical development, with several front-runners including Pfizer-BioNTech well positioned to begin delivering vaccines in the near future. But procuring bodies such as governments and supranational organizations face many challenges in getting vaccines in the hands of patients.
Playing with our lives
President Donald Trump promised health insurance coverage for all, with lower deductibles and lower fees while the Republican congressional versions were the antithesis of that. With seven years to plan, the GOP members of Congress came up with bills that were unacceptable to too many of their own constituents. So then they proposed Repeal Now, Replace Later.
Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
Although significant progress in the treatment of both common and rare cancers has been made in the past decade, there has been significant concern about the cost, and especially the value, of certain new oncology drugs. These concerns touch upon a number of issues regarding the price of these medicines, the value they deliver and the ability of healthcare systems to fund them [1].
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anthony
Contact Anthony, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack